Showing 1-10 of 96

Page
per page
Set Descending Direction

  1. Sku: iAAV04401
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...


  2. Sku: iAAV04403
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...


  3. Sku: iAAV04404
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...


  4. Sku: iAAV04405
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...


  5. Sku: iAAV04406
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...


  6. Sku: iAAV04408
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...


  7. Sku: iAAV04409
    Price: $795.00
    Unit: 5 x 200 µl
    Among all viral vectors, recombinant Adeno-Associated Virus (AAV) is the most promising candidate for gene therapy owing to its non-integrating nature and lack of pathogenicity animal models. Other key attributes making AAV a very attractive tool in...




Showing 1-10 of 96

Page
per page
Set Descending Direction